BAYER HEALTHCARE AG
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- May 31, 2016 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,222 Total Citation Count
- Aug 23, 1978 Earliest Filing
- 196 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0022,283 Neuropeptide Y receptor Y5 and nucleic acid sequencesDec 20, 01Jan 30, 03[C07H, C12P, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7858394 Test methods for determining the intracellular concentration of cyclic nucleotidesMar 06, 04Dec 28, 10[G01N]
7258971 Methods and compositions for treating urological disorders using carboxypeptidase Z identified as 8263Jan 14, 04Aug 21, 07[C12Q]
7063951 Members of the capsaicin/vanilloid receptor family of proteins and uses thereofJun 02, 00Jun 20, 06[G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8501755 Tetrahydropyridothienopyrimidine compounds and methods of use thereofExpiredMar 20, 07Aug 06, 13[A61K, C07D]
8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesExpiredNov 02, 06Apr 30, 13[A61K, C07D, A61P]
2010/0129,321 DIARYL UREA FOR TREATING VIRUS INFECTIONSAbandonedDec 06, 06May 27, 10[A61K, C07D, A61P]
2010/0105,090 SECRETED LUCIFERASE MLUC7 AND USE THEREOFAbandonedJan 26, 08Apr 29, 10[C07H, C12Q, C12N, A01K, C07K]
2010/0048,641 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating DiseasesAbandonedFeb 16, 07Feb 25, 10[A61K, C07D, A61P]
2010/0016,299 Substituted benzoxepino-isoxazoles and use thereofAbandonedJun 28, 07Jan 21, 10[A61K, C07D, A61P]
2009/0288,658 Antibiotic Formulations, Unit Doses, Kits, and MethodsAbandonedDec 22, 08Nov 26, 09[A61K, C07G, A61M]
2009/0258,877 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USEAbandonedDec 12, 08Oct 15, 09[A61K, C07D, A61P]
7589195 Tetrahydrobenzo[d]azepin-2-one derivatives and the use thereof for treating cardiovascular diseasesWithdrawnFeb 01, 05Sep 15, 09[A61K, C07D]
2009/0136,920 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)AbandonedApr 18, 05May 28, 09[C07H, C12Q, C12N, G01N, C07K]
2009/0082,328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityAbandonedMay 09, 08Mar 26, 09[A61K, C07D, C07C, A61P]
2009/0023,753 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic AgentsAbandonedFeb 24, 06Jan 22, 09[A61K, C07D, A61P]
2008/0286,260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)AbandonedMar 11, 05Nov 20, 08[A61K, C12Q, G01N, A61P]
7449198 Stable salts of O-acetylsalicylic acid with basic amino acidsExpiredAug 09, 04Nov 11, 08[A61K]
2008/0255,202 Phenylthioacetic Acid Derivatives and Use ThereofAbandonedMar 26, 05Oct 16, 08[A61K, C07D, A61P]
2008/0248,462 Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)AbandonedOct 12, 04Oct 09, 08[C07H, C12Q, G01N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.